Compare IDEXX Laboratories, Inc. (IDXX) vs MINISO Group Holding Ltd (MNSO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs MINISO Group Holding Ltd — how do they compare? IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B), while MINISO Group Holding Ltd trades at $9.6 (market cap $2.65B). The key difference: IDEXX Laboratories, Inc. is far larger — about 15.3× MINISO Group Holding Ltd's market cap, and MINISO Group Holding Ltd pays a 7.34% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold IDEXX Laboratories, Inc. for 46 Days and MINISO Group Holding Ltd for 25 Days on average.
| IDXX | MNSO | |
|---|---|---|
Market Cap | $40.43B | $2.65B |
Volume | 692,164 | 747,763 |
Sector | Health | Consumer Cyclical |
52-Week High | $766.68 | $22.75 |
52-Week Low | $504.70 | $8.60 |
Typical Hold Time | 46 Days | 25 Days |
Enterprise Value | $41.32B | $3.52B |
Dividend Yield | — | 7.34% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $513.14, up 1.28% on the day, with a bearish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $4.27 exceeding the $3.94 estimate. Revenue grew to $4.3 billion in 2025, and net income margin expanded to 25.03%. Recent acquisitions like CoVetAI aim to enhance veterinary workflow intelligence.
The outlook remains positive given robust profitability and analyst consensus, but risks include foreign exchange headwinds and competitive pressures. With a consensus price target of $665, representing ~30% upside, the stock offers growth potential for investors comfortable with its premium valuation multiples.
MNSO trades at $9.07, up 1.45% on the day, amid mixed technical signals and recent earnings volatility. The stock exhibits a bearish technical trend with neutral oscillators, while fundamentals show solid revenue growth to $23.5B in 2026 and a net income margin of 5.35%. Recent news highlights insider buying by the CFO and analyst optimism despite some earnings misses.
The outlook is cautiously optimistic given attractive valuations like a P/E of 14.76 and 60% analyst buy ratings, but risks include overseas margin pressure and inconsistent quarterly EPS performance. The stock's investment case hinges on execution of operational improvements and sustained domestic growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About MINISO Group Holding Ltd
MINISO Group Holding Ltd is a global lifestyle product retailer known for its aesthetically pleasing, high-quality, and low-cost goods. The company operates a network of branded stores worldwide, offering a diverse range of merchandise, including household goods, cosmetics, toys, and digital accessories. MINISO's business model emphasizes rapid product iteration, efficient supply chain management, and a joint venture and franchise partner network to facilitate its global expansion.
Read more on MNSO →
